DE3879811T2 - Pharmazeutische Zusammensetzung und ihre Verwendung. - Google Patents

Pharmazeutische Zusammensetzung und ihre Verwendung.

Info

Publication number
DE3879811T2
DE3879811T2 DE88113428T DE3879811T DE3879811T2 DE 3879811 T2 DE3879811 T2 DE 3879811T2 DE 88113428 T DE88113428 T DE 88113428T DE 3879811 T DE3879811 T DE 3879811T DE 3879811 T2 DE3879811 T2 DE 3879811T2
Authority
DE
Germany
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE88113428T
Other languages
English (en)
Other versions
DE3879811D1 (de
Inventor
Ulrich Dr Kuebler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kuebler Dr GmbH
Original Assignee
Kuebler Dr GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kuebler Dr GmbH filed Critical Kuebler Dr GmbH
Application granted granted Critical
Publication of DE3879811D1 publication Critical patent/DE3879811D1/de
Publication of DE3879811T2 publication Critical patent/DE3879811T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/004Aftersun preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
DE88113428T 1987-08-25 1988-08-18 Pharmazeutische Zusammensetzung und ihre Verwendung. Expired - Fee Related DE3879811T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8927187A 1987-08-25 1987-08-25

Publications (2)

Publication Number Publication Date
DE3879811D1 DE3879811D1 (de) 1993-05-06
DE3879811T2 true DE3879811T2 (de) 1993-10-07

Family

ID=22216682

Family Applications (1)

Application Number Title Priority Date Filing Date
DE88113428T Expired - Fee Related DE3879811T2 (de) 1987-08-25 1988-08-18 Pharmazeutische Zusammensetzung und ihre Verwendung.

Country Status (3)

Country Link
EP (1) EP0304802B1 (de)
JP (1) JP2519988B2 (de)
DE (1) DE3879811T2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2634120B1 (fr) * 1988-07-13 1990-09-14 Transphyto Sa Nouvelles compositions cosmetiques a base de chromone-carboxylates
TW233264B (de) * 1992-02-03 1994-11-01 Otsuka Pharma Co Ltd
DE10031457C2 (de) * 2000-06-28 2002-12-12 Jean Krutmann Verwendung von O-beta-Hydroxyethylrutosid oder dessen Aglycon zur systemischen Behandlung und Prophylaxe von UV-induzierten Dermatosen und unerwünschten Langzeitfolgen von UV-Bestrahlungen
US6846846B2 (en) 2001-10-23 2005-01-25 The Trustees Of Columbia University In The City Of New York Gentle-acting skin disinfectants
AU2003216213B2 (en) 2002-02-07 2008-10-02 The Trustees Of Columbia University In The City Of New York Zinc salt compositions for the prevention of mucosal irritation from spermicides and microbicides
US7879365B2 (en) 2002-02-07 2011-02-01 The Trustees Of Columbia University In The City Of New York Zinc salt compositions for the prevention of dermal and mucosal irritation
CN102309473A (zh) * 2003-07-17 2012-01-11 纽约市哥伦比亚大学托管会 含有季铵化合物及精油和/或精油成分的协同组合的抗微生物组合物
DE10337863A1 (de) * 2003-08-18 2005-03-17 Merck Patent Gmbh Verwendung von Chromen-4-on-Derivaten
DE102004016250A1 (de) * 2004-04-02 2005-10-20 Merck Patent Gmbh Chromon-Komplexe
GB0617191D0 (en) * 2006-08-31 2006-10-11 York Pharma Plc Improvements in pharmaceutical compositions
DE102007013366A1 (de) 2007-03-16 2008-09-18 Merck Patent Gmbh Verwendung von Chroman-4-on-Derivaten
FR2949196B1 (fr) 2009-08-21 2013-01-11 Oreal Procede de coloration capillaire mettant en oeuvre un colorant chromenique ou chromanique
SI3104853T1 (sl) 2014-02-10 2020-03-31 Respivant Sciences Gmbh Zdravljenje s stabilizatorji mastocitov za sistemske motnje
US20150224078A1 (en) 2014-02-10 2015-08-13 Patara Pharma, LLC Methods for the Treatment of Lung Diseases with Mast Cell Stabilizers
WO2017027402A1 (en) 2015-08-07 2017-02-16 Patara Pharma, LLC Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
US10238625B2 (en) 2015-08-07 2019-03-26 Respivant Sciences Gmbh Methods for the treatment of mast cell related disorders with mast cell stabilizers
CA3035528A1 (en) 2016-08-31 2018-03-08 Respivant Sciences Gmbh Cromolyn compositions for treatment of chronic cough due to idiopathic pulmonary fibrosis
EP3522983A4 (de) 2016-10-07 2020-06-03 Respivant Sciences GmbH Cromolynzusammensetzung zur behandlung von lungenfibrose
WO2021094296A1 (en) 2019-11-12 2021-05-20 INSERM (Institut National de la Santé et de la Recherche Médicale) Use of mast cell stabilizer for the treatment of heart failure with preserved ejection fraction

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4225600A (en) * 1977-05-04 1980-09-30 Fisons Limited Compositions and methods for treating certain skin conditions

Also Published As

Publication number Publication date
JP2519988B2 (ja) 1996-07-31
EP0304802B1 (de) 1993-03-31
JPH0196134A (ja) 1989-04-14
EP0304802A2 (de) 1989-03-01
DE3879811D1 (de) 1993-05-06
EP0304802A3 (en) 1990-03-28

Similar Documents

Publication Publication Date Title
DE3582399D1 (de) Purin-derivate und ihre pharmazeutische verwendung.
ATE107130T1 (de) Zusammensetzung und ihre verwendung.
DE68901417D1 (de) Pharmazeutische zusammensetzung.
DE122004000023I2 (de) Pharmazeutische Zusammensetzung
DE3879811T2 (de) Pharmazeutische Zusammensetzung und ihre Verwendung.
DE3869167D1 (de) Phenyltriazol-derivate und insectizid.
DE3873797T2 (de) E-prostaglandine und ihre anti-ulcusanwendung.
DE3677445D1 (de) 2-substituierte-e-kondensierte(1,5-c)-pyrimidine, pharmazeutische zubereitungen und ihre verwendung.
FI893643A (fi) Farmaceutiska kompositioner.
DE3583765D1 (de) Hydantoinderivate und diese enthaltende pharmazeutische zusammensetzungen.
DE3881576T2 (de) Anthracyclinderivate und ihre Verwendung.
DK133587D0 (da) 2-heterocyclylthio-penemer, deres anvendelse og farmaceutisk komposition indeholdende forbindelserne
DE69009204D1 (de) Hydroxyperoxide und ihre Verwendung.
DE3883352T2 (de) Muramylpeptid-Derivate und ihre Verwendung.
DE3888608D1 (de) Einbettzusammensetzung und ihre Verwendung.
ATA133288A (de) Pharmazeutische zusammensetzung
DE69021162T2 (de) Substituierte Dibenzonfurane und ihre Verwendung.
DE68907609D1 (de) Arzneimittelzusammensetzung.
DE3871159D1 (de) Pharmazeutische und tieraerztliche zusammensetzungen.
ATE78161T1 (de) 4-aroylimidazol-2-on enthaltende pharmazeutische zusammensetzung.
DE3585143D1 (de) Azulenderivate und deren pharmazeutische verwendung.
DE3670083D1 (de) Pharmazeutische pyrrolizidinverbindungen und -zusammensetzungen und ihre herstellung.
DE3667915D1 (de) Pharmazeutische zusammensetzung.
DE69003003T2 (de) Pharmazeutische Zusammensetzung.
IT1224244B (it) Composizione farmaceutica anoressizzante comprendente 5-idrossitrpofano

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee